Navigation Links
Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Date:10/17/2007

BASINGSTOKE, England, Oct. 17 /PRNewswire-FirstCall/ -- Below is updated text of Shire plc's conference call notification. Please note U.S. release times and conference call times have been updated from an earlier release.

Shire PLC (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) the global specialty biopharmaceutical company, will announce third quarter 2007 earnings on Thursday 1 November 2007.

Results press release will be issued at: 12:00 GMT / 08:00 ET

Investor meeting and conference call time: 14:30 GMT / 10:30 ET

Live conference call for investors:

Matthew Emmens, Chief Executive Officer and Angus Russell, Chief Financial Officer will host the live conference call for investors at 14:30 GMT/10:30 ET.

Please RSVP ssalah@shire.com (T: +44(0)1256-894-160) for this conference call.

The details of the conference call are as follows:

UK dial in: +44(0)800-953-0810,

US dial in: +1-866-789-2220,

International dial in: +44(0)1452-560-068,

Password/Conf ID: 20443623#

Live Webcast:*

http://www.shire.com/shire/InvestorRelations/events.jsp?tn=2&m1=33

Replay:

A replay of the presentation will be available for two weeks by phone and by webcast for one year. Details are as follows:

UK dial in: +44(0)800-953-1533,

US dial in: +1-866-247-4222,

International dial in: +44(0)1452-55-00-00,

Pin code: 20443623#

Webcast replay:*

http://www.shire.com/shire/InvestorRelations/events.jsp?tn=2&m1=33

* Email verification is required

Notes to editors

Shire PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.


'/>"/>
SOURCE Shire PLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Visions: Broderick says Wisconsin should be in top third in venture capital
2. Third Wave files countersuit vs. Digene in patent case
3. Third Wave reports net loss of $18.9M for 2006
4. Stratagene to pay Third Wave $10.75M in patent case
5. Third Wave responds to Digene patent lawsuit
6. Third Wave seeks approval of Cystic Fibrosis test
7. Third Wave Technologies to raise $14.9M through private debt
8. Venture capital above $6B for third straight quarter
9. Third Wave reports $5.2M third quarter loss
10. Third Wave reports another loss, stronger sales
11. Napier joins board of Third Wave Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... NC (PRWEB) , ... September 19, 2017 , ... ... on band technologies for surgical applications, announced today that two new patents have ... , Michael Albert, MD, Co-Founder of Band-LOK, said, “We continue to explore additional ...
(Date:9/18/2017)... ... September 18, 2017 , ... ... the move of the SPIE Digital Library ( http://www.spiedigitallibrary.org ) on 15 August ... create an improved user experience and incorporate a number of enhancements and new ...
(Date:9/18/2017)... ... September 18, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces Bryan Coddington ... What: Digital Transformation in Medical Device – The Journey to FDA Compliant Field ...
(Date:9/15/2017)... ... September 15, 2017 , ... ... what it calls an ‘Internal Seed B’ round of financing, totaling $600,000. ... was completed using a ‘SAFE’ documentation structure at a company valuation of $10M. ...
Breaking Biology Technology:
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 /PRNewswire/ ... leader in dairy research, today announced a new collaboration ... reduce the chances that the global milk supply is ... dairy project, Cornell University has become the newest academic ... Supply Chain, a food safety initiative that includes IBM ...
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
Breaking Biology News(10 mins):